Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered
• 1.4 Market Analysis by Type
  • 1.4.1 Global Digital Therapeutics Market Size Growth Rate by Type (2014-2025)
  • 1.4.2 B2C
  • 1.4.3 B2B
• 1.5 Market by Application
  • 1.5.1 Global Digital Therapeutics Market Share by Application (2014-2025)
  • 1.5.2 Preventive
  • 1.5.3 Treatment/Care
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Digital Therapeutics Market Size
• 2.2 Digital Therapeutics Growth Trends by Regions
  • 2.2.1 Digital Therapeutics Market Size by Regions (2014-2025)
  • 2.2.2 Digital Therapeutics Market Share by Regions (2014-2019)
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis

3 Market Share by Key Players

• 3.1 Digital Therapeutics Market Size by by Players
  • 3.1.1 Global Digital Therapeutics Revenue by by Players (2014-2019)
  • 3.1.2 Global Digital Therapeutics Revenue Market Share by by Players (2014-2019)
  • 3.1.3 Global Digital Therapeutics Market Concentration Ratio (CR5 and HHI)
• 3.2 Digital Therapeutics Key Players Head office and Area Served
• 3.3 Key Players Digital Therapeutics Product/Solution/Service
• 3.4 Date of Enter into Digital Therapeutics Market
• 3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application

• 4.1 Global Digital Therapeutics Market Size by Type (2014-2019)
• 4.2 Global Digital Therapeutics Market Size by Application (2014-2019)

5 United States

• 5.1 United States Digital Therapeutics Market Size (2014-2019)
• 5.2 Digital Therapeutics Key Players in United States
• 5.3 United States Digital Therapeutics Market Size by Type
• 5.4 United States Digital Therapeutics Market Size by Application

6 Europe

• 6.1 Europe Digital Therapeutics Market Size (2014-2019)
• 6.2 Digital Therapeutics Key Players in Europe
• 6.3 Europe Digital Therapeutics Market Size by Type
• 6.4 Europe Digital Therapeutics Market Size by Application

7 China

• 7.1 China Digital Therapeutics Market Size (2014-2019)
• 7.2 Digital Therapeutics Key Players in China
• 7.3 China Digital Therapeutics Market Size by Type
• 7.4 China Digital Therapeutics Market Size by Application

8 Japan

• 8.1 Japan Digital Therapeutics Market Size (2014-2019)
• 8.2 Digital Therapeutics Key Players in Japan
• 8.3 Japan Digital Therapeutics Market Size by Type
• 8.4 Japan Digital Therapeutics Market Size by Application

9 Southeast Asia

• 9.1 Southeast Asia Digital Therapeutics Market Size (2014-2019)
• 9.2 Digital Therapeutics Key Players in Southeast Asia
• 9.3 Southeast Asia Digital Therapeutics Market Size by Type
• 9.4 Southeast Asia Digital Therapeutics Market Size by Application

10 India

• 10.1 India Digital Therapeutics Market Size (2014-2019)
• 10.2 Digital Therapeutics Key Players in India
• 10.3 India Digital Therapeutics Market Size by Type
• 10.4 India Digital Therapeutics Market Size by Application

11 Central & South America

• 11.1 Central & South America Digital Therapeutics Market Size (2014-2019)
• 11.2 Digital Therapeutics Key Players in Central & South America
• 11.3 Central & South America Digital Therapeutics Market Size by Type
• 11.4 Central & South America Digital Therapeutics Market Size by Application

12 International Players Profiles

• 12.1 Proteus Digital Health, Inc
  • 12.1.1 Proteus Digital Health, Inc Company Details
  • 12.1.2 Company Description and Business Overview
  • 12.1.3 Digital Therapeutics Introduction
  • 12.1.4 Proteus Digital Health, Inc Revenue in Digital Therapeutics Business (2014-2019)
  • 12.1.5 Proteus Digital Health, Inc Recent Development
• 12.2 Omada Health, Inc
  • 12.2.1 Omada Health, Inc Company Details
  • 12.2.2 Company Description and Business Overview
  • 12.2.3 Digital Therapeutics Introduction
  • 12.2.4 Omada Health, Inc Revenue in Digital Therapeutics Business (2014-2019)
  • 12.2.5 Omada Health, Inc Recent Development
• 12.3 Welldoc, Inc
  • 12.3.1 Welldoc, Inc Company Details
  • 12.3.2 Company Description and Business Overview
  • 12.3.3 Digital Therapeutics Introduction
  • 12.3.4 Welldoc, Inc Revenue in Digital Therapeutics Business (2014-2019)
  • 12.3.5 Welldoc, Inc Recent Development
• 12.4 Livongo Health
  • 12.4.1 Livongo Health Company Details
  • 12.4.2 Company Description and Business Overview
  • 12.4.3 Digital Therapeutics Introduction
  • 12.4.4 Livongo Health Revenue in Digital Therapeutics Business (2014-2019)
  • 12.4.5 Livongo Health Recent Development
• 12.5 Noom Inc
  • 12.5.1 Noom Inc Company Details
  • 12.5.2 Company Description and Business Overview
  • 12.5.3 Digital Therapeutics Introduction
  • 12.5.4 Noom Inc Revenue in Digital Therapeutics Business (2014-2019)
  • 12.5.5 Noom Inc Recent Development
• 12.6 Ginger.Io, Inc
  • 12.6.1 Ginger.Io, Inc Company Details
  • 12.6.2 Company Description and Business Overview
  • 12.6.3 Digital Therapeutics Introduction
  • 12.6.4 Ginger.Io, Inc Revenue in Digital Therapeutics Business (2014-2019)
  • 12.6.5 Ginger.Io, Inc Recent Development
• 12.7 Propeller Health
  • 12.7.1 Propeller Health Company Details
  • 12.7.2 Company Description and Business Overview
  • 12.7.3 Digital Therapeutics Introduction
  • 12.7.4 Propeller Health Revenue in Digital Therapeutics Business (2014-2019)
  • 12.7.5 Propeller Health Recent Development
• 12.8 2morrow Inc
  • 12.8.1 2morrow Inc Company Details
  • 12.8.2 Company Description and Business Overview
  • 12.8.3 Digital Therapeutics Introduction
  • 12.8.4 2morrow Inc Revenue in Digital Therapeutics Business (2014-2019)
  • 12.8.5 2morrow Inc Recent Development
• 12.9 Canary Health Inc
  • 12.9.1 Canary Health Inc Company Details
  • 12.9.2 Company Description and Business Overview
  • 12.9.3 Digital Therapeutics Introduction
  • 12.9.4 Canary Health Inc Revenue in Digital Therapeutics Business (2014-2019)
  • 12.9.5 Canary Health Inc Recent Development
• 12.10 Mango Health Inc
  • 12.10.1 Mango Health Inc Company Details
  • 12.10.2 Company Description and Business Overview
  • 12.10.3 Digital Therapeutics Introduction
  • 12.10.4 Mango Health Inc Revenue in Digital Therapeutics Business (2014-2019)
  • 12.10.5 Mango Health Inc Recent Development

13 Market Forecast 2019-2025

• 13.1 Market Size Forecast by Regions
• 13.2 United States
• 13.3 Europe
• 13.4 China
• 13.5 Japan
• 13.6 Southeast Asia
• 13.7 India
• 13.8 Central & South America
• 13.9 Market Size Forecast by Product (2019-2025)
• 13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
    • 15.1.1.1 Research Programs/Design
    • 15.1.1.2 Market Size Estimation
    • 12.1.1.3 Market Breakdown and Data Triangulation
  • 15.1.2 Data Source
    • 15.1.2.1 Secondary Sources
    • 15.1.2.2 Primary Sources
• 15.2 Disclaimer

Digital therapeutics refers to health or social care interventions delivered through a smart device to support healthy behaviors and provide therapeutic effects. Digital therapies/programs are cost-effective and have the potential to improve patient engagement and bring a substantial change in patients’ health. Owing to these advantages, digital therapeutics is increasingly being prescribed to help manage long-term conditions such as diabetes, insomnia, and asthma.
In 2018, the global Digital Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Digital Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Digital Therapeutics development in United States, Europe and China.

The key players covered in this study
Proteus Digital Health, Inc
Omada Health, Inc
Welldoc, Inc
Livongo Health
Noom Inc
Ginger.Io, Inc
Propeller Health
2morrow Inc
Canary Health Inc
Mango Health Inc

Market segment by Type, the product can be split into
B2C
B2B

Market segment by Application, split into
Preventive
Treatment/Care

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Digital Therapeutics status, future forecast, growth opportunity, key market and key players.
To present the Digital Therapeutics development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Digital Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.